Primary thromboembolic prevention in multiple myeloma patients: An exploratory meta-analysis on aspirin use

Multiple myeloma (MM) is a common hematological disorder, often complicated by venous thromboembolism, especially during treatment with immunomodulatory drugs. Acetylsalicylic acid (ASA) has been extensively used as thromboprophylaxis but its rationale is unclear and the efficacy versus low-molecular weight heparins (LMWH) is still matter of debate. European and American guidelines suggest different approaches and the optimal antithrombotic strategy is yet to be established.
Source: Seminars in Hematology - Category: Hematology Authors: Source Type: research